Oral anticancer medicines: risk of incorrect dosing

Advice for healthcare professionals on potentially fatal outcomes of oral anticancer medicines if they are not prescribed, dispensed or administered properly.

Article date: January 2008

The National Patient Safety Agency (NPSA) is alerting all healthcare professionals who use oral anticancer medicines about potentially fatal outcomes if incorrect doses are prescribed, dispensed, or administered. Risks are increased if healthcare practitioners who are not cancer specialists prescribe, dispense, or administer these medicines.

NPSA is issuing guidance to all clinical staff that the prescribing, dispensing, and administering of oral anticancer medicine should be carried out and monitored to the same standard as that for injected cancer therapy.

Article citation: Drug Safety Update Jan 2008: Vol 1, Issue 6: 10

Published 11 December 2014